ACM
LABD icon

ADAR1 Capital Management’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

ADAR1 Capital Management’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-840
Closed -$49.1K – 263
2024
Q3 		$49.1K Buy
+840
New +$51K 0.01% 216

Other funds holding LABD

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HT
Headlands Technologies Chicago, Illinois $878M AUM 44.8% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ADAR1 Capital Management's LABD Position: Q4 2024 in Review

ADAR1 Capital Management sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q4 2024, closing a stake of 840 shares — an estimated $49.1K sold.

ADAR1 Capital Management first reported a position in LABD in Q3 2024 and held it in 1 quarter. The position peaked at $49.1K in Q3 2024. 17 funds tracked by Wall St. Rank hold LABD as of Q4 2024.

  • ADAR1 Capital Management reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q4 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 840 Direxion Daily S&P Biotech Bear 3X ETF shares in Q4 2024, an estimated $49.1K.
  • ADAR1 Capital Management first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2024 and held it in 1 quarter.
  • ADAR1 Capital Management's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $49.1K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q4 2024.

Based on ADAR1 Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.